3LM5
Crystal Structure of human Serine/Threonine Kinase 17B (STK17B) in complex with Quercetin
3LM5 の概要
| エントリーDOI | 10.2210/pdb3lm5/pdb |
| 関連するPDBエントリー | 3EHA |
| 分子名称 | Serine/threonine-protein kinase 17B, 3,5,7,3',4'-PENTAHYDROXYFLAVONE (3 entities in total) |
| 機能のキーワード | stk17b, serine/threonine kinase 17b, drak2, dap kinase related apoptosis-inducing protein kinase 2, death-associated protein kinase-related 2, structural genomics, structural genomics consortium, sgc, apoptosis, atp-binding, kinase, nucleotide-binding, nucleus, phosphoprotein, serine/threonine-protein kinase, transferase |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 37629.32 |
| 構造登録者 | Ugochukwu, E.,Soundararajan, M.,Rellos, P.,Fedorov, O.,Phillips, C.,Wang, J.,Hapka, E.,Filippakopoulos, P.,Chaikuad, A.,Pike, A.C.W.,Carpenter, L.,Vollmar, M.,von Delft, F.,Bountra, C.,Arrowsmith, C.H.,Weigelt, J.,Edwards, A.,Knapp, S.,Structural Genomics Consortium (SGC) (登録日: 2010-01-29, 公開日: 2010-03-16, 最終更新日: 2023-09-06) |
| 主引用文献 | Picado, A.,Chaikuad, A.,Wells, C.I.,Shrestha, S.,Zuercher, W.J.,Pickett, J.E.,Kwarcinski, F.E.,Sinha, P.,de Silva, C.S.,Zutshi, R.,Liu, S.,Kannan, N.,Knapp, S.,Drewry, D.H.,Willson, T.M. A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation. J.Med.Chem., 63:14626-14646, 2020 Cited by PubMed Abstract: STK17B is a member of the death-associated protein kinase family and has been genetically linked to the development of diverse diseases. However, the role of STK17B in normal and disease pathology is poorly defined. Here, we present the discovery of thieno[3,2-d] pyrimidine (), a high-quality chemical probe for this understudied "dark" kinase. is an ATP-competitive inhibitor that showed remarkable selectivity over other kinases including the closely related STK17A. X-ray crystallography of and related thieno[3,2-d]pyrimidines bound to STK17B revealed a unique P-loop conformation characterized by a salt bridge between R41 and the carboxylic acid of the inhibitor. Molecular dynamic simulations of STK17B revealed the flexibility of the P-loop and a wide range of R41 conformations available to the apo-protein. The isomeric thieno[2,3-d]pyrimidine () was identified as a negative control compound. The >100-fold lower activity of on STK17B was attributed to the reduced basicity of its pyrimidine N1. PubMed: 33215924DOI: 10.1021/acs.jmedchem.0c01174 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.29 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






